MITO - Stealth Biotherapeutics chief financial officer Robert Weiskopf leaves company
- Stealth BioTherapeutics ( NASDAQ: MITO ) said on Friday Robert Weiskopf, its chief financial officer, is leaving the company effective September 30.
- Weiskopf joined Stealth in 2019 following the initial public offering.
For further details see:
Stealth Biotherapeutics chief financial officer Robert Weiskopf leaves company